# HSEF v5.3 review: Caloric Restriction → Lifespan Extension

> Sources: 60 primary reports; claims: 65; verified: 65; unverified: 0. Verification is bounded attribution. Access: 3 partial-body and 57 complete abstract/status examinations. Cutoff: 2026-10-04. No complete-paper audit or blinded calibration claimed.
>
> **Adversarial review:** Generated by Sol 6.1; adversarially reviewed by Claude Opus 5.5 (Anthropic) on 2026-10-06. 0 corrections applied (see ADVERSARIAL REVIEW AND APPROVAL). Status: **Approved as revised.**

## AT A GLANCE

**Caloric restriction causally extends lifespan in defined animal settings (Ζ) and improves some human functional outcomes (Ε); extending human lifespan remains Γ.**

| Level | Confidence | Causal role | Momentum | Stability | Divergence |
|---|---|---|---|---|---|
| Γ — Mechanistically plausible, partial system support | Moderate | reinforcing / stabilizing factor | Mechanistic only | Stable | Contested |

**Deciding experiment:** Follow a predeclared human restriction contrast long enough for adjudicated incident disease, disability and mortality, with measured intake, nutrient adequacy, adherence and competing harms. In parallel, validate whether intervention-induced changes in candidate aging measures mediate those outcomes across independent exposure contrasts; lifelong natural experiments or defensible exposure instruments can complement randomized follow-up.

**Belief versus evidence:** The registered scope-matched human-lifespan gate SC3 returns Γ. SC1 animal survival reaches Ζ and SC4 human function reaches Ε; the candidate unified mechanism SC2 is separately Γ and is not an added necessary clause of the generic exposure claim. All preregistered aggregation sensitivities happen to return Γ.

**Best-supported rival:** Parallel nutrient-sensing and repair pathways. Matched-calorie/timing factorial interventions plus adult-specific loss/rescue of proposed nodes distinguish a single coordinator from parallel nutrient and timing routes.

## COMPETING MECHANISTIC MODELS

**Rank 1: Parallel nutrient-sensing and repair pathways (Ζ).** Diet alters several partially overlapping pathways and physiological tradeoffs. Host genetic, immune, transcriptional and temporal contrasts identify different routes [35,38,43,44,46–57]. A network description is not a fully identified common pathway; specific mediators remain protocol-dependent.

**Rank 2: Meal timing/fasting and dietary composition (Ε).** Feeding phase and fasting explain additional effects beyond calorie amount. Matched-calorie schedules move survival, and 2026 TRF maps sex dependence [2,3,58]. Spread calorie restriction still extends median survival, so timing alone is insufficient [2].

**Rank 3: Specific nutrient restriction (Ε).** Individual nutrient balance can change longevity independent of generic calorie dose. Isoleucine and methionine/folate manipulations support specified animal settings [4,57]. No one nutrient explains all calorie restriction protocols or human survival.

**Rank 4: Hormetic stress response (Ε).** Moderate stress responses support protection under selected protocols. Worm neuronal redox interventions and mouse hormone rescue identify bounded stress routes [49,54]. Stress resistance is distinct from organismal longevity and does not generalize automatically.

**Rank 5: One unified nutrient-sensing coordinator (Γ).** A single conserved node explains all CR lifespan effects. Conserved AMPK, sirtuin, TOR and transcriptional responses make unity plausible. Necessity differs by protocol, tissue and species; metabolic benefit can dissociate from survival [36,37,40,44,49].

The tournament does not alter the nominal level. Compatible pathways and flexible alternatives are not automatically proved by explaining observations.

## FULL REVIEW

### Registered claim and scope

Sustained caloric restriction without malnutrition causally extends lifespan across model organisms and humans.

Human-scope central claim is governed by SC3 under the index scope-matched rule. SC2 is evaluated as the indexed candidate mechanism, not added as a necessary clause of the generic lifespan claim. SC4 distinguishes functional benefit from mortality.

Selection: public-interest rank 3 from the editorial ranking compiled 2026-09-23; categorical prior verdicts were visible. Private fresh review; earlier documents are preserved.

### Evidence and causal interpretation

The registered proposition includes humans, so its score must not be determined by the abundance of successful laboratory survival studies. It also does not require one unified mechanism: that indexed candidate is SC2, scored separately. Animal lifespan, human function, molecular indicators and stress resistance are different outcomes. Their separation explains why animal SC1 can reach Ζ while the human-lifespan gate SC3 remains Γ.

Adult-onset, genetically diverse mice provide a strong recent anchor. The primary body reports randomized dietary groups beginning at six months and clear survival extension. It also documents extended daily fasting and a weekend triple ration, so the intervention is not a pure calorie-amount contrast. Physiological network/path analysis is explicitly presented as proxies for latent processes rather than direct mediator proof [1]. This preserves the real survival result while limiting the mechanistic inference.

The matched-calorie schedule study supplies a different discriminator. Spreading reduced food throughout day/night still increased median survival; fasting and aligning feeding to the nocturnal active period produced larger gains. Equal total calories therefore do not erase the effect of timing, and timing alone does not account for the entire calorie contrast. Maximum-survival significance differed among schedules [2]. The fasting-separation work reinforces protocol dependence [3]; the 2026 TRF study maps differing male survival and both-sex health responses with voluntary calorie reduction in the strongest group [58].

Primate studies extend the question to a long-lived species but are not uniform. Wisconsin's adult-onset study reported fewer age-associated deaths and delayed pathology [6]. NIA did not show improved survival under its protocol [7]. Their later joint comparison discusses diet, onset and baseline intake, using those same cohorts [8]. The small additional rhesus cohort is suggestive rather than definitive [9]. A conserved health effect and context-dependent survival cannot be flattened into either universal benefit or wholesale refutation.

Mechanistic specificity is substantial within particular models. HIF/IRE1 tissue rescue, microRNA/Wnt adult switching, Foxo3 loss, nonsense-mediated-decay perturbation and mitochondrial remodeling connect nutrition to survival [35,43,45,46,51]. The portfolio supports causation in defined systems. It does not identify one coordinator operating identically everywhere. Different restriction paradigms and genetic backgrounds can use different routes.

Negative and bypass contrasts are especially informative. Yeast restriction has Sir2-independent routes [36,37]. NQO1 knockout retains tested CR survival and functional benefits [40]. Adipose Rictor deletion removes insulin sensitization while preserving CR fitness and longevity [44]. These findings reject treating a familiar favorable metabolic marker as a necessary survival mediator. Candidate injury protection and hormone rescue likewise need distinction from directly tested lifespan [48,54].

Nutrient composition supplies an alternative to a calorie-only account. Isoleucine restriction improves frailty and longevity in genetically heterogeneous mice with sex differences [4]. Methionine restriction plus folate can preserve longevity while restoring reproductive capacity in flies [57]. These experiments refine dietary mechanisms; they do not prove human lifespan extension or that all apparent laboratory dietary effects are nutritionally adequate.

CALERIE demonstrates feasibility and biologic effects under supervised human restriction. Achieved exposure was lower than the intended prescription, and primary metabolic/temperature contrasts were not uniformly positive at both timepoints [16]. Its cardiometabolic analysis reports favorable randomized risk-factor changes [17]. Molecular, senescence, thymic and muscle studies add plausible routes and functional tissue observations [18,23–26]. Multiple reports of this cohort are not multiple independent human trials of survival.

The methylation paper is explicit about the remaining bridge. DunedinPACE changed modestly, while PhenoAge and GrimAge did not significantly change [27]. The selected primary discussion says that surrogate validation requires showing that intervention-induced measure changes account for clinical disease and mortality effects. A marker can predict future mortality and respond to treatment without proving that its treatment response predicts survival benefit. The current result supports investigation, not a quantified extension of human life.

Human functional benefit is nevertheless not restricted to biomarker changes. CALERIE randomized restriction improved selected self-reported quality-of-life measures in nonobese adults [59]. A separate randomized trial in older adults with obesity improved physical performance through diet-induced weight loss, with larger gains from combining exercise; diet alone also cost lean mass and hip bone density [60]. Those baseline and endpoint contexts justify SC4 Ε. They do not establish longer disease-free survival in healthy nonobese people.

At the registered human gate, Γ reflects mechanistic plausibility and partial translational support. Animal Ζ remains reachable and supported, with named distinct controls rather than reference-count inflation. Human functional Ε retains its mapped benefits and harms. A future human clinical trajectory contrast or genuinely validated intervention surrogate would cross the next boundary without requiring that every participant be followed to the theoretical maximum human lifespan.

## HYPOTHESIS STATE EVALUATION FRAMEWORK (HSEF v5.3)

<!-- consensus-consistency-2026-10-09 -->
### Consensus consistency validation — 9 October 2026

This is a transparently unblinded consistency check; it does not establish historical Consensus use. The frozen review cutoff remains **2026-10-04**; fresh Consensus discovery is considered only to check claim scope and sources already in the frozen evidence inventory. Original score/source counts are preserved.

**Grade:** Γ / Moderate (unchanged). The registered central human lifespan claim is SC3 Γ; animal survival (SC1 Ζ) and human functional outcomes (SC4 Ε) do not upgrade the human lifespan endpoint. **Frozen inventory:** 60 primary reports, 65 claims.

**Consensus sources:** Pro browser response from https://consensus.app/search/caloric-restriction-lifespan-extension/hf_Mm4R0QXm5_QF3UMqz0A/ is preserved verbatim as `browser-thread.json` and `consensus-browser-response.md`; MCP search/fetch raw JSON also saved in this folder. Citation markers in the raw documents are unmodified. The Consensus surfaced papers are discovery pointers; the checks below use original source entries and PubMed abstracts recorded in the frozen review.

**Primary comparisons (all already in frozen evidence inventory):**

| PMID / DOI | Review source | Original-source access recorded | Comparison to claim |
|---|---|---|---|
| 19590001 / 10.1126/science.1173635 | #6, primary rhesus survival study | Complete PubMed abstract + linked-status metadata; no full paper/supplement audit | Wisconsin rhesus cohort reported survival advantage and fewer age-related deaths under CR. Supports animal lifespan in this setting, not human lifespan. |
| 22932268 / 10.1038/nature11432 | #7, primary NIA rhesus study | Complete PubMed abstract + linked-status metadata; no full paper/supplement audit | NIA cohort showed health benefits without survival improvement. Limits universal primate-survival generalization. |
| 28094793 / 10.1038/ncomms14063 | #8, primary cross-cohort comparison | Complete PubMed abstract + linked-status metadata; no full paper/supplement audit | Compared the same Wisconsin and NIA cohorts; not an independent third replication. Reports divergent survival and shared health effects. |
| 27136347 / 10.1001/jamainternmed.2016.1189 | #59, CALERIE 2 RCT | Complete PubMed abstract + linked-status metadata; no full paper/supplement audit | Randomized 220 non-obese adults for 2 years; measured mood, quality of life, sleep, sexual function—not mortality or lifespan. |

The search surfaced several CALERIE biomarker reports and primate survival material. These do not establish human survival extension or a validated mortality surrogate. Source count remains 60: these are existing rows, and any newly surfaced publications are not silently added to the original ledger. No score change is warranted.

This dated supplement adds source reconciliation to the original review. Its original narrative, registered scope, source inventory and grades remain historical records. A dated adversarial approval record exists for the separately identified caloric-restriction.review.md (2026-10-06; see edition-approval-audit.json). Its scope is that recorded edition. This supplement has no separate approval and no coverage is inferred from topic identity. New sources described here are supplemental and are not counted in the original inventory.
<!-- end-consensus-consistency -->


### Subclaim matrix and aggregation

| Subclaim | Scope | Level | Decision |
|---|---|---|---|
| SC1 Caloric restriction extends lifespan in multiple model organisms. | named species, genotype, sex, diet and restriction schedules determined before outcome | Ζ | SC1 reaches Ζ within named experimental contexts. Controlled survival, adult-onset diverse-mouse restriction, calorie/timing separation and genetic pathway contrasts converge beyond one strain or species [1–4,6–8,35–44,46]. Contextual contradictions and healthspan mismatch prevent Η in this bounded appraisal. |
| SC2 CR lifespan effects are mediated by a unified nutrient-sensing mechanism. | experimental model organisms | Γ | SC2 remains Γ for one unified nutrient-sensing coordinator. Several pathways are causally identified in particular systems, but Sir2, NQO1 and insulin-sensitivity contrasts show that familiar routes are not uniformly necessary [35–44,46–57]. Individual constrained pathways can reach Ε without proving unity. |
| SC3 Caloric restriction extends human lifespan. | adults without malnutrition | Γ | SC3 remains Γ for human lifespan extension. Human randomized intervention changes physiological and molecular measures and some function, but no examined study measures extension of human survival or validates those measures as CR-mediated mortality surrogates [16–29,59,60]. |
| SC4 Caloric restriction improves measured human healthspan-related function. | baseline populations and intervention periods of human CR trials | Ε | SC4 reaches Ε for defined human functional outcomes. Randomized restriction improves selected quality-of-life outcomes, and diet-induced weight loss improves physical performance in older adults with obesity [59,60]. Baseline context, follow-up, masking, lean/bone loss and endpoint distinctions bound the conclusion. |

Preregistered aggregation: scope-matched. The registered scope-matched human-lifespan gate SC3 returns Γ. SC1 animal survival reaches Ζ and SC4 human function reaches Ε; the candidate unified mechanism SC2 is separately Γ and is not an added necessary clause of the generic exposure claim. All preregistered aggregation sensitivities happen to return Γ. Sensitivities: weakest-link Γ; primary-subclaim Γ; scope-matched Γ.

### Decisive-perturbation inventory and causal tally

[1] Adult-onset restriction extended survival in genetically diverse female mice; health measures did not uniformly track survival. Restriction included daily/weekend fasting, and measured-trait path analysis is not selective mediator intervention.

[2] Equal-calorie regimens separated restriction, fasting and circadian timing; spread feeding still extended median survival. The single male strain and differing maximum-survival results limit generalization; timing contributes substantially.

[3] Separated feeding regimens attributed key mouse CR benefits to prolonged fasting. The tested protocols do not establish that all calorie restriction effects in all species are solely fasting effects.

[4] Isoleucine restriction improved frailty/metabolism and extended lifespan in genetically heterogeneous mice of both sexes. Nutrient-specific effects and sex differences distinguish this intervention from pure calorie reduction.

[5] CR preserved beta-cell structure/function and reduced turnover but impaired adaptive proliferation during high-fat feeding. Cell longevity and beta-cell markers are not a new organismal survival endpoint in this report.

[6] Adult-onset Wisconsin rhesus restriction reduced age-associated deaths and disease onset. Age-related mortality at this report is not identical to an all-cause complete-survival result; human lifespan is not measured.

[7] The NIA rhesus CR regimen did not improve survival despite reported health benefits. Differences in baseline intake, diet and age of initiation limit direct comparison with Wisconsin.

[8] Joint longitudinal analysis compared the divergent rhesus survival results and conserved health benefits. These are the same NIA/Wisconsin cohorts, not a third independent primate replication.

[9] Long-term laboratory rhesus data associated restriction with lower mortality and better insulin sensitivity. Only eight restricted monkeys and unequal cohort sizes limit causal precision and human inference.

[10] Long-term rhesus CR increased selected activity measures in one age group. Movement, pacing and stereotypies do not by themselves establish lifespan extension or uniformly improved function.

[11] Rhesus CR preserved upper-leg mass/fiber features during early sarcopenia. It did not prevent mitochondrial deletion abnormalities; shared Wisconsin animals are not new survival replication.

[12] Rhesus muscle metabolic/tissue profiles linked CR to preserved muscle and physical activity. Integrated profiling suggests candidate routes without selectively testing their necessity.

[13] Reported NIA primary measurements showed favorable cardiovascular/metabolic risk changes, including short-term changes in older monkeys. The report's broader background is not counted as new evidence; risk-factor change is not a human mortality outcome.

[14] Longitudinal rhesus liver profiling showed CR-associated metabolic and RNA-processing changes. Predictive network analysis does not prove a unified required mediator.

[16] CALERIE achieved sustained moderate restriction and favorable risk measures; the primary resting-metabolic residual contrast was significant at twelve but not twenty-four months. Neither mortality nor extended healthy lifespan was measured; the linked erratum's fine impact remains unresolved.

[17] CALERIE exploratory randomized outcomes improved several cardiometabolic risk factors over two years. Risk factors, including insulin sensitivity, are not validated CR-mediated lifespan surrogates or a new independent cohort.

[18] Six-month CR changed human muscle mitochondrial DNA and transcripts and reduced DNA damage. Key mitochondrial enzyme activities were unchanged; molecular markers do not establish lifespan extension.

[19] Six-month CR changed bone turnover without significant total/hip density loss in young overweight adults. Short duration and nutrient support do not exclude longer-term bone or fracture harm.

[23] CALERIE samples showed reduced circulating senescence-associated markers and an adipose gene-set signal. Markers and machine-learning prediction of metabolic change do not establish clinical aging reversal.

[24] Human CR improved thymopoiesis; mouse Pla2g7 deletion improved inflammation and metabolic phenotypes. Human correlation plus mouse deletion is not selectively identified human mediator necessity or mortality benefit.

[25] Human adipose SPARC reduction motivated inducible adult mouse downregulation and adipocyte deletion with metabolic/inflammatory benefit. CR-like disease physiology is not a measured general lifespan outcome or uniquely necessary CR coordinator.

[26] CALERIE muscle biopsies showed transcription/splicing changes with preserved strength despite minor lean loss. Statistical pathway mediation and muscle quality are not proof of longer human survival.

[27] Post hoc CALERIE analysis changed DunedinPACE but not PhenoAge/GrimAge significantly. The primary discussion explicitly requires clinical endpoint follow-up to validate intervention-surrogate mediation; correction remains attached.

[30] Lithocholic acid improved aged-mouse function and extended worm/fly lifespan with AMPK dependence. Mouse functional rescue is distinct from mouse survival; linked correction details were not fully examined.

[31] LCA-TULP3-sirtuin-vATPase signaling and a muscle mutant linked AMPK to aged-mouse function and worm/fly longevity. Companion work shares the LCA programme and is not an independent lab replication or complete CR necessity test.

[32] Genetic/pharmacologic polyamine-pathway perturbation abrogated fasting-related autophagy and longevity/health effects in models. Human metabolite changes are not a human longevity intervention; fasting is not identical to calorie restriction.

[33] Slower RNA polymerase variants extended worm/fly lifespan while restriction reversed age-linked elongation changes. Human cell division capacity is not organismal human lifespan; the complete CR pathway is not isolated.

[34] Middle-age low-dose metformin improved male-mouse survival/function; high dose was toxic without calorie reduction. A partial CR mimetic is a comparator, not evidence that one conserved CR coordinator is sufficient across humans.

[35] HIF-1/egl-9 perturbation and tissue rescue linked nutrient-dependent worm longevity to IRE-1. Nutrient context and tissue-specificity constrain the pathway; cross-species unity is not shown.

[36] Moving yeast mothers removed CR replicative longevity, restored by supplements or conditioned medium; the transferable factor was Sir2-independent. Replicative cell aging and media ecology differ from adult animal or human aging.

[37] Yeast Hst2 mediated Sir2-independent lifespan extension under restriction. Redundant sirtuin routes challenge single-Sir2 necessity and do not establish a human longevity mechanism.

[38] Worm p38-ATF7 immune signaling had to be intact but downregulated for dietary longevity. Immune and nutrient pathways are context dependent; correction-body details remain unexamined.

[39] Emory-mouse restriction extended median survival and reduced cataract/cancer measures. Single-background findings and some adverse tissue signs limit universal healthspan alignment.

[40] NQO1 knockout retained CR benefits for lifespan, metabolic function and carcinogen outcomes. NQO1 upregulation is not necessary for these tested benefits; retained pathways do not identify a unified alternative.

[41] Temporary fasting reduced parental worm mortality but produced adverse multigenerational fitness/survival tradeoffs. Generation and exposure schedules limit a universal benefit claim.

[42] Yeast glucose restriction/PKA perturbation linked respiration and Sir2/NAD to replicative lifespan. Strain and replicative-aging conditions do not establish the same necessary route in other species.

[43] Adult-onset microRNA/Wnt switching was required for worm dietary longevity. The temporal switch helps separate development, but the specific route remains a worm context.

[44] Adipose Rictor deletion blocked CR insulin sensitization while preserving fitness and lifespan extension. This directly separates a familiar metabolic marker from the required survival mediator.

[45] RNAi tests identified nonsense-mediated-decay genes required for worm dietary longevity. Transcript/translatome associations alone are not mediator proof; RNAi survival tests retain their specific scope.

[46] Foxo3-deficient mice failed to show significant CR lifespan extension while cancer suppression persisted. The reported absence of significance and one genetic setting do not establish universal Foxo3 necessity across all CR protocols.

[47] Lamin downregulation altered dietary-restriction size/fat phenotypes via RAGC/mTOR localization in worms. This report does not supply a new organismal lifespan rescue result in the examined abstract.

[48] Sulfur-amino-acid/CGL perturbations blocked DR hepatic stress protection; transsulfuration changes appeared across longevity models. Injury resistance and across-model pathway occurrence do not alone prove a common lifespan mediator.

[49] Complex-I inhibition extended worm lifespan without reduced intake; neuronal ROS/PMK/SKN perturbations blocked the effect despite AMPK/sirtuin independence. A DR-like pharmacological route is not proof that every dietary protocol uses that mechanism.

[50] Food odors shortened DR worm lifespan through an olfactory brain-gut octopamine/AMPK route. Perceived food cues modify dietary longevity; mouse primary-cell signaling is not mouse or human lifespan.

[51] Fusion/fission, fatty-acid oxidation and peroxisomal perturbations separated DR/AMPK/fasting worm longevity requirements. Different dynamic versus stabilized network requirements constrain a unified explanation.

[52] mekk-3 knockdown induced a dietary-like longevity state without compromised food intake in worms. A genetic mimetic distinguishes sensing from calorie dose but does not establish human extension.

[53] A cep-1 strain blocked genetic but not nongenetic dietary longevity; authors implicated background mutations. The result cannot be attributed specifically to p53 without resolving linked genetic background.

[54] Corticosterone replacement restored CR attenuation of edema in hormone-insufficient mice. Anti-inflammatory challenge response is not directly measured lifespan mediation.

[55] SIRT4 loss and CR altered beta-cell GDH/insulin regulation through NAD-dependent modification. This cell/tissue metabolic result does not establish organismal lifespan necessity or a uniform sirtuin activation rule.

[57] Folate supplementation preserved methionine-restriction fly longevity while restoring reproductive capacity. Defined nutrient balance can separate tradeoffs; this is not pure calorie restriction or human lifespan.

[58] Nightly time-restricted feeding improved both-sex health measures, while survival extended only in male mice under the shorter window. The strongest group also voluntarily restricted calories; sex and calorie/time factors remain material.

[59] CALERIE randomized restriction improved selected mood, general-health and sexual-function questionnaire outcomes. Self-report and unblinded diet intervention limit interpretation; benefits are not durable disease-free survival.

[60] Randomized diet-induced weight loss improved physical performance in older obese adults; exercise combination produced larger gains. Diet alone also reduced lean mass and hip density; the obesity-treatment context does not establish nonobese human lifespan extension.

Tally: 53 discriminating contrasts. Null and negative contrasts are discriminators, not positive threshold crossings. Reports and replications are not independent causal lines. Diet, genetic, drug-mimetic and negative contrasts are counted as discriminators, not all as positive CR longevity tests. No human mortality-extension test is claimed; single-cell longevity, stress protection and molecular profiles are distinct endpoints.

### Cap audit, precedence and Β/Γ/Δ boundary

Animal dietary and genetic interventions cross thresholds within their tested organism, background and schedule. Multispecies survival evidence is assessed as a set, without re-capping it as a single-strain experiment. Human functional intervention earns SC4 causality, whereas a marker that predicts mortality is not yet a validated mediator/surrogate of CR-caused mortality reduction. The same generic mechanism is not silently substituted for the registered human-lifespan claim.

Gamma hard-rule audit: “ROS change measurements alone”, “NAD level change measurements alone”, “Mitochondrial metrics alone” and “Senescence marker changes alone” constrain isolated marker inferences. “Single-species or single-strain evidence” does not describe the assembled SC1 set, but limits individual model legs. “Biomarker-only improvement without organismal benefit” constrains human lifespan inference; functional SC4 outcomes are retained separately.

SC3 cap: “Biomarker-only improvement without organismal benefit” SC3 remains Γ for human lifespan extension. Human randomized intervention changes physiological and molecular measures and some function, but no examined study measures extension of human survival or validates those measures as CR-mediated mortality surrogates [16–29,59,60].

SC1 field-valid definition: “
- Genetic or pharmacologic intervention producing reproducible lifespan/healthspan extension
- Must separate developmental effects from true aging effects
- Biomarker change alone does NOT satisfy this threshold” Positive full-scope result: yes. SC1 reaches Ζ within named experimental contexts. Controlled survival, adult-onset diverse-mouse restriction, calorie/timing separation and genetic pathway contrasts converge beyond one strain or species [1–4,6–8,35–44,46]. Contextual contradictions and healthspan mismatch prevent Η in this bounded appraisal.

SC2 field-valid definition: “
- Genetic or pharmacologic intervention producing reproducible lifespan/healthspan extension
- Must separate developmental effects from true aging effects
- Biomarker change alone does NOT satisfy this threshold” Positive full-scope result: no. SC2 remains Γ for one unified nutrient-sensing coordinator. Several pathways are causally identified in particular systems, but Sir2, NQO1 and insulin-sensitivity contrasts show that familiar routes are not uniformly necessary [35–44,46–57]. Individual constrained pathways can reach Ε without proving unity.

SC3 field-valid definition: “
- Genetic or pharmacologic intervention producing reproducible lifespan/healthspan extension
- Must separate developmental effects from true aging effects
- Biomarker change alone does NOT satisfy this threshold” Positive full-scope result: no. SC3 remains Γ for human lifespan extension. Human randomized intervention changes physiological and molecular measures and some function, but no examined study measures extension of human survival or validates those measures as CR-mediated mortality surrogates [16–29,59,60].

SC4 field-valid definition: “
- Genetic or pharmacologic intervention producing reproducible lifespan/healthspan extension
- Must separate developmental effects from true aging effects
- Biomarker change alone does NOT satisfy this threshold” Positive full-scope result: yes. SC4 reaches Ε for defined human functional outcomes. Randomized restriction improves selected quality-of-life outcomes, and diet-induced weight loss improves physical performance in older adults with obesity [59,60]. Baseline context, follow-up, masking, lean/bone loss and endpoint distinctions bound the conclusion.

### Upward threshold ladder

SC1 Δ: “Requires at least one intervention changing lifespan or healthspan in a way consistent with the hypothesis.” Satisfied: yes. 

SC1 Ε: “Requires causal effect in constrained contexts, backgrounds, or species.” Satisfied: yes. 

SC1 Ζ: “Requires:
- Reproducible intervention effects
- Mechanistic narrowing
- Evidence not reducible to general sickness, caloric reduction, or developmental artifacts” Satisfied: yes. 

SC1 Η: “Requires:
- Robust cross-context intervention evidence
- Mechanistic specificity
- Strong alignment of lifespan/healthspan outcomes” Satisfied: no. For Η, align survival and functional aging across independently controlled species/backgrounds with narrowed exposure/pathway attribution and tradeoff assessment.

SC2 Δ: “Requires at least one intervention changing lifespan or healthspan in a way consistent with the hypothesis.” Satisfied: no. Show adult-specific loss and rescue of a common proposed node consistently mediating CR survival across predeclared organisms and feeding/nutrient protocols.

SC3 Δ: “Requires at least one intervention changing lifespan or healthspan in a way consistent with the hypothesis.” Satisfied: no. Measure human clinical survival or validate intervention-mediated changes in a surrogate against chronic disease, disability and mortality; natural experiments or defensible exposure instruments are eligible equivalents.

SC4 Δ: “Requires at least one intervention changing lifespan or healthspan in a way consistent with the hypothesis.” Satisfied: yes. 

SC4 Ε: “Requires causal effect in constrained contexts, backgrounds, or species.” Satisfied: yes. 

SC4 Ζ: “Requires:
- Reproducible intervention effects
- Mechanistic narrowing
- Evidence not reducible to general sickness, caloric reduction, or developmental artifacts” Satisfied: no. For Ζ, independent functional clinical effects with narrowed mechanism, replicated beyond one trial family and excluding weight-loss-only or nonspecific care explanations.

Upper ladder: Controlled multispecies survival, dose/timing comparisons, adult-onset interventions and gene loss/rescue are eligible equivalents, carrying animal SC1 to Ζ. Human exposure genetics, lifelong natural experiments or validated clinical mediation could also qualify without waiting for a deliberate lifespan RCT. The examined FTO adherence analysis is not such an exposure instrument, and CALERIE's prognostic measures do not establish intervention-mediated mortality. No observational leg is re-capped over the entire animal set.

Independence: Ζ refers to the narrow animal survival subclaim and the parallel-pathway model's actually demonstrated settings. Independence rests on intervention assignment/feeding control, genotype-specific mechanistic discrimination and the long-lived primate context excluding different errors; repeated cohorts do not add lines. CALERIE phase2 reports share NCT00427193, phase1 pooled nutritional data overlap phase1 mitochondrial/bone work, and the 2017 primate analysis reuses Wisconsin/NIA cohorts. LCA companion papers share one programme. No human survival convergence is asserted.

Assigned exposure with feeding-factor separation [1, 2]: Adult diverse-genotype randomization reduces baseline selection and developmental-delay explanations; matched-calorie schedules distinguish amount from timing. These are one exposure intervention family, not two independent lines by paper count.

Genetic necessity and dissociation [46, 44, 40, 43]: Loss-of-function contrasts identify or reject specific required routes and separate insulin sensitization, cancer suppression and developmental Wnt effects from survival. A generic metabolic biomarker explanation cannot generate these discriminating results.

Long-lived primate protocol comparison [6, 7]: A long-lived primate setting challenges a mouse-only tumor/husbandry account and independently maps diet/onset limits. The two primate cohorts and their combined report are not counted again as independent reports.

### Falsification and pitfalls

Necessity fails when the proposed pathway is removed. Sir2-independent routes, NQO1-null retention and Rictor-mediated insulin-resistance retention challenge uniform coordinator claims [36,37,40,44]. Additional downgrade: False.

Effects disappear across strains or species. Primate and sex/protocol heterogeneity map limits; these do not erase independently positive experimental contexts [7,58]. Additional downgrade: False.

Pathway manipulation changes biomarkers but not lifespan/healthspan. Human mortality was not measured; it is incorrect to label missing survival data a demonstrated negative survival effect [16–29]. Additional downgrade: False.

13. Therapeutic effect misread as mechanistic proof. Risk improvement and weight-loss benefit are not proof of human aging reversal.

16. Untested generalization confused with mapped boundaries. Animal genotype, sex and dietary limits are retained without denying causal effects.

21. A universal cap re-applied to a convergent evidence set. The strong model evidence is not dragged down by an associative human clock leg; the human outcome remains a separate question.

22. Scope fitted to the result. Species, genotype and diet are defined before outcome; long-lived responders do not define success.

### Adversarial steelman: above, then below

The strongest Δ case for human lifespan is the reproducible animal effect combined with randomized human physiological, immune and functional benefits. The convergence supports translation plausibility. The missing identifying experiment is a human aging/survival trajectory result, or a genuinely validated intervention surrogate; a prognostic clock is insufficient.

The strongest Β case is that human longevity has no direct outcome and its putative markers may merely follow weight loss. It understates controlled animal survival and mechanistically narrowed routes plus functional human effects. The assembled case supplies mechanistic plausibility beyond pure aging association, supporting Γ without replacing SC3 with SC1 or SC4.

Reject Δ at the human lifespan gate because the clinical trajectory/surrogate-validation experiment is missing; reject Β because mechanistic/functional intervention support is present. The separate animal Ζ and functional human Ε remain intact.

### Final score, causal direction and M/S/D

The registered scope-matched human-lifespan gate SC3 returns Γ. SC1 animal survival reaches Ζ and SC4 human function reaches Ε; the candidate unified mechanism SC2 is separately Γ and is not an added necessary clause of the generic exposure claim. All preregistered aggregation sensitivities happen to return Γ.

Direction procedure: controlled diet assignments precede outcome, excluding a solely downstream label (step 1); functional and survival perturbations exclude epiphenomenon (step 2). One necessary, sufficient, rate-limiting human aging initiator is not identified (step 3), and restriction is not a uniformly necessary prerequisite for longevity (step 4). Nutrient and timing signals modify/stabilize aging-related trajectories in defined settings, matching step 5 for the mechanism at the broad claimed scope. This role label does not deny that assigned restriction causes animal survival differences.

Momentum: Mechanistic only. Named primary programmes include LCA/TULP3-sirtuin-AMPK experiments [30,31], polyamine-hypusination work [32] and meal-timing survival contrasts [2,58]. This search verified their completed results, not an ongoing next-boundary human mortality trial.

Stability: Stable. No specifically verified pending CR clinical survival or validated-surrogate result was identified in this bounded search; completed CALERIE reports are not pending triggers.

Divergence: Contested; no single implied-level arithmetic. These dimensions do not change level or confidence.

## PROPOSED DECISIVE EXPERIMENTS

Follow a predeclared human restriction contrast long enough for adjudicated incident disease, disability and mortality, with measured intake, nutrient adequacy, adherence and competing harms. In parallel, validate whether intervention-induced changes in candidate aging measures mediate those outcomes across independent exposure contrasts; lifelong natural experiments or defensible exposure instruments can complement randomized follow-up.

Readout: Adjudicated survival, multimorbidity, disability, physical function and fractures, with candidate surrogate mediation. Controls: Baseline age/BMI/sex and nutrient adequacy; distinguish feeding timing and composition; account for adherence without selecting post-outcome responders. Supporting: Reproducible favorable human clinical aging trajectories attributable to restriction, with independently validated mediator or exposure specificity. Falsifying: Adequate sustained exposure without clinical benefit, harms offsetting benefit, or marker changes failing to mediate hard outcomes.

## KNOWLEDGE GAPS

Does restriction extend human survival independent of baseline obesity treatment?

Which model mechanisms are required under which calorie, nutrient and timing protocols?

What is the net human balance of function, lean mass, bone and immune effects?

Can aging algorithms become validated intervention surrogates rather than merely prognostic measures?

How do dose, sex, age of onset and sustainable adherence modify benefit?

## REVIEWER NOTES

Sixty primary reports were admitted after complete abstract/status examination. Three partial primary-body examinations cover diverse-mouse survival/timing/mediation, matched-calorie mouse survival, and the human methylation report's surrogate limitations. A mechanistic commentary, PMID35466532, was excluded after actual reading despite its generic Journal Article label. Primary NIA measurements within PMID10630589 are admitted only as its measured empirical component. CALERIE and primate shared-study families are explicit. Ravussin, Waziry, LCA and innate-immunity linked correction details were not fully examined; fine corrected numbers are not used for level assignment. This assesses evidence, not an individualized diet recommendation.

Search leads, reviews, protocols and correction notices do not pad the primary count. Downloaded XML does not earn examination credit. Linked notices remain attached; unexamined correction details limit inference. This is a coordinator source/claim consistency assessment, not independent blinded calibration.

## ADVERSARIAL REVIEW AND APPROVAL

**Authoring model:** Sol 6.1. **Adversarial reviewer:** Claude Opus 5.5 (Anthropic). **Date:** 2026-10-06.

**Scope of checks:** All 60 reference PMIDs re-fetched with the PubMed MCP tool get_article_metadata and cross-checked against NCBI E-utilities (title, first author, journal, year, DOI): 60/60 correct; no retraction or expression of concern; 4 linked errata, all disclosed on the cards. 18 load-bearing claims spot-checked against PubMed abstracts: refs 1, 2, 3, 4, 6, 9, 16, 27, 34, 36, 39, 40, 44, 46, 53, 58, 59, 60. Scoring logic checked: scope-matched gate SC3, reported alternatives (weakest-link min = Γ), SC1 Ζ independence basis, SC4 Ε, rubric 06 Δ/Ε/Ζ/Η quotations.

**Findings and corrections**

| ID | Severity | Location | Original → corrected | Evidence |
|---|---|---|---|---|
| — | — | — | No correction required | — |

**Rejected findings (checked, no change)**

- SC1 Ζ cites the NIA rhesus cohort [7], which showed no survival benefit, among its independence lines. The review labels it as mapping diet/onset limits, not as positive replication, and Ζ is independently carried by yeast/worm/mouse genetic necessity and dissociation contrasts. No change.
- SC3 Γ versus Β: randomized human CR changes physiology and function, so it is more than association. Γ versus Δ: no human survival or validated surrogate endpoint exists. Γ is the defensible boundary.
- Scope-matched gate: the central claim's human limb (SC3) governs, and the weakest-link sensitivity Γ is correct (lowest of Ζ, Γ, Γ, Ε).
- Claims about Wisconsin vs NIA primates, CALERIE RMR-residual significance at 12 but not 24 months, DunedinPACE slowing without PhenoAge/GrimAge change, Rictor/NQO1/Foxo3 dissociations, 2026 TRF male-only lifespan extension, and Villareal lean-mass/BMD loss with diet alone: all match the abstracts.
- Year difference [11] (2011 print vs 2010 e-pub): acceptable under convention.

**Residual limitations**

- Verification was mostly at abstract depth. The 3 receipted partial-body passages were not re-read in this review.
- Scorecard provenance_header.generated_by reads 'Codex; HSEF v5.3' and was not altered.

**Approval:** Following adversarial review and the corrections listed above, the revised document is approved. — Claude Opus 5.5 (Anthropic), 2026-10-06.

## REFERENCES

1. Di Francesco A, Deighan AG, Litichevskiy L et al. Dietary restriction impacts health and lifespan of genetically diverse mice. Nature. 2024. [PMID 39385029](https://pubmed.ncbi.nlm.nih.gov/39385029/). DOI: 10.1038/s41586-024-08026-3. Access: full_text_partial. Study: PMID39385029.

2. Acosta-Rodríguez V, Rijo-Ferreira F, Izumo M et al. Circadian alignment of early onset caloric restriction promotes longevity in male C57BL/6J mice. Science (New York, N.Y.). 2022. [PMID 35511946](https://pubmed.ncbi.nlm.nih.gov/35511946/). DOI: 10.1126/science.abk0297. Access: full_text_partial. Study: PMID35511946.

3. Pak HH, Haws SA, Green CL et al. Fasting drives the metabolic, molecular and geroprotective effects of a calorie-restricted diet in mice. Nature metabolism. 2021. [PMID 34663973](https://pubmed.ncbi.nlm.nih.gov/34663973/). DOI: 10.1038/s42255-021-00466-9. Access: abstract_metadata. Study: PMID34663973.

4. Green CL, Trautman ME, Chaiyakul K et al. Dietary restriction of isoleucine increases healthspan and lifespan of genetically heterogeneous mice. Cell metabolism. 2023. [PMID 37939658](https://pubmed.ncbi.nlm.nih.gov/37939658/). DOI: 10.1016/j.cmet.2023.10.005. Access: abstract_metadata. Study: PMID37939658.

5. Dos Santos C, Cambraia A, Shrestha S et al. Calorie restriction increases insulin sensitivity to promote beta cell homeostasis and longevity in mice. Nature communications. 2024. [PMID 39433757](https://pubmed.ncbi.nlm.nih.gov/39433757/). DOI: 10.1038/s41467-024-53127-2. Access: abstract_metadata. Study: PMID39433757.

6. Colman RJ, Anderson RM, Johnson SC et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science (New York, N.Y.). 2009. [PMID 19590001](https://pubmed.ncbi.nlm.nih.gov/19590001/). DOI: 10.1126/science.1173635. Access: abstract_metadata. Study: Wisconsin-rhesus.

7. Mattison JA, Roth GS, Beasley TM et al. Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study. Nature. 2012. [PMID 22932268](https://pubmed.ncbi.nlm.nih.gov/22932268/). DOI: 10.1038/nature11432. Access: abstract_metadata. Study: NIA-rhesus.

8. Mattison JA, Colman RJ, Beasley TM et al. Caloric restriction improves health and survival of rhesus monkeys. Nature communications. 2017. [PMID 28094793](https://pubmed.ncbi.nlm.nih.gov/28094793/). DOI: 10.1038/ncomms14063. Access: abstract_metadata. Study: Wisconsin+NIA-joint.

9. Bodkin NL, Alexander TM, Ortmeyer HK et al. Mortality and morbidity in laboratory-maintained Rhesus monkeys and effects of long-term dietary restriction. The journals of gerontology. Series A, Biological sciences and medical sciences. 2003. [PMID 12634286](https://pubmed.ncbi.nlm.nih.gov/12634286/). DOI: 10.1093/gerona/58.3.b212. Access: abstract_metadata. Study: PMID12634286.

10. Weed JL, Lane MA, Roth GS et al. Activity measures in rhesus monkeys on long-term calorie restriction. Physiology & behavior. 1997. [PMID 9226348](https://pubmed.ncbi.nlm.nih.gov/9226348/). DOI: 10.1016/s0031-9384(97)00147-9. Access: abstract_metadata. Study: NIA-rhesus.

11. McKiernan SH, Colman RJ, Lopez M et al. Caloric restriction delays aging-induced cellular phenotypes in rhesus monkey skeletal muscle. Experimental gerontology. 2011. [PMID 20883771](https://pubmed.ncbi.nlm.nih.gov/20883771/). DOI: 10.1016/j.exger.2010.09.011. Access: abstract_metadata. Study: Wisconsin-rhesus.

12. Rhoads TW, Clark JP, Gustafson GE et al. Molecular and Functional Networks Linked to Sarcopenia Prevention by Caloric Restriction in Rhesus Monkeys. Cell systems. 2020. [PMID 31982367](https://pubmed.ncbi.nlm.nih.gov/31982367/). DOI: 10.1016/j.cels.2019.12.002. Access: abstract_metadata. Study: Wisconsin-rhesus.

13. Lane MA, Ingram DK, Roth GS et al. Calorie restriction in nonhuman primates: effects on diabetes and cardiovascular disease risk. Toxicological sciences : an official journal of the Society of Toxicology. 1999. [PMID 10630589](https://pubmed.ncbi.nlm.nih.gov/10630589/). DOI: 10.1093/toxsci/52.2.41. Access: abstract_metadata. Study: NIA-rhesus.

14. Rhoads TW, Burhans MS, Chen VB et al. Caloric Restriction Engages Hepatic RNA Processing Mechanisms in Rhesus Monkeys. Cell metabolism. 2018. [PMID 29514073](https://pubmed.ncbi.nlm.nih.gov/29514073/). DOI: 10.1016/j.cmet.2018.01.014. Access: abstract_metadata. Study: PMID29514073.

15. Raman A, Baum ST, Colman RJ et al. Metabolizable energy intake during long-term calorie restriction in rhesus monkeys. Experimental gerontology. 2007. [PMID 17618073](https://pubmed.ncbi.nlm.nih.gov/17618073/). DOI: 10.1016/j.exger.2007.05.008. Access: abstract_metadata. Study: Wisconsin-rhesus.

16. Ravussin E, Redman LM, Rochon J et al. A 2-Year Randomized Controlled Trial of Human Caloric Restriction: Feasibility and Effects on Predictors of Health Span and Longevity. The journals of gerontology. Series A, Biological sciences and medical sciences. 2015. [PMID 26187233](https://pubmed.ncbi.nlm.nih.gov/26187233/). DOI: 10.1093/gerona/glv057. Access: abstract_metadata. Study: CALERIE2-NCT00427193.

17. Kraus WE, Bhapkar M, Huffman KM et al. 2 years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial. The lancet. Diabetes & endocrinology. 2019. [PMID 31303390](https://pubmed.ncbi.nlm.nih.gov/31303390/). DOI: 10.1016/S2213-8587(19)30151-2. Access: abstract_metadata. Study: CALERIE2-NCT00427193.

18. Civitarese AE, Carling S, Heilbronn LK et al. Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS medicine. 2007. [PMID 17341128](https://pubmed.ncbi.nlm.nih.gov/17341128/). DOI: 10.1371/journal.pmed.0040076. Access: abstract_metadata. Study: CALERIE1-NCT00099151.

19. Redman LM, Rood J, Anton SD et al. Calorie restriction and bone health in young, overweight individuals. Archives of internal medicine. 2008. [PMID 18809812](https://pubmed.ncbi.nlm.nih.gov/18809812/). DOI: 10.1001/archinte.168.17.1859. Access: abstract_metadata. Study: CALERIE1-NCT00099151.

20. Fleischer JG, Das SK, Bhapkar M et al. Associations between the timing of eating and weight-loss in calorically restricted healthy adults: Findings from the CALERIE study. Experimental gerontology. 2022. [PMID 35598698](https://pubmed.ncbi.nlm.nih.gov/35598698/). DOI: 10.1016/j.exger.2022.111837. Access: abstract_metadata. Study: CALERIE2-NCT00427193.

21. Grigolon RB, Brietzke E, Trevizol AP et al. Caloric restriction, resting metabolic rate and cognitive performance in Non-obese adults: A post-hoc analysis from CALERIE study. Journal of psychiatric research. 2020. [PMID 32485641](https://pubmed.ncbi.nlm.nih.gov/32485641/). DOI: 10.1016/j.jpsychires.2020.05.018. Access: abstract_metadata. Study: CALERIE2-NCT00427193.

22. Dorling JL, Belsky DW, Racette SB et al. Association between the FTO rs9939609 single nucleotide polymorphism and dietary adherence during a 2-year caloric restriction intervention: Exploratory analyses from CALERIE™ phase 2. Experimental gerontology. 2021. [PMID 34543722](https://pubmed.ncbi.nlm.nih.gov/34543722/). DOI: 10.1016/j.exger.2021.111555. Access: abstract_metadata. Study: CALERIE2-NCT00427193.

23. Aversa Z, White TA, Heeren AA et al. Calorie restriction reduces biomarkers of cellular senescence in humans. Aging cell. 2024. [PMID 37961856](https://pubmed.ncbi.nlm.nih.gov/37961856/). DOI: 10.1111/acel.14038. Access: abstract_metadata. Study: CALERIE2-NCT00427193.

24. Spadaro O, Youm Y, Shchukina I et al. Caloric restriction in humans reveals immunometabolic regulators of health span. Science (New York, N.Y.). 2022. [PMID 35143297](https://pubmed.ncbi.nlm.nih.gov/35143297/). DOI: 10.1126/science.abg7292. Access: abstract_metadata. Study: CALERIE2-NCT00427193.

25. Ryu S, Spadaro O, Sidorov S et al. Reduction of SPARC protects mice against NLRP3 inflammasome activation and obesity. The Journal of clinical investigation. 2023. [PMID 37781916](https://pubmed.ncbi.nlm.nih.gov/37781916/). DOI: 10.1172/JCI169173. Access: abstract_metadata. Study: CALERIE2-NCT00427193.

26. Das JK, Banskota N, Candia J et al. Calorie restriction modulates the transcription of genes related to stress response and longevity in human muscle: The CALERIE study. Aging cell. 2023. [PMID 37823711](https://pubmed.ncbi.nlm.nih.gov/37823711/). DOI: 10.1111/acel.13963. Access: abstract_metadata. Study: CALERIE2-NCT00427193.

27. Waziry R, Ryan CP, Corcoran DL et al. Effect of long-term caloric restriction on DNA methylation measures of biological aging in healthy adults from the CALERIE trial. Nature aging. 2023. [PMID 37118425](https://pubmed.ncbi.nlm.nih.gov/37118425/). DOI: 10.1038/s43587-022-00357-y. Access: full_text_partial. Study: CALERIE2-NCT00427193.

28. Redman LM, Kraus WE, Bhapkar M et al. Energy requirements in nonobese men and women: results from CALERIE. The American journal of clinical nutrition. 2014. [PMID 24257721](https://pubmed.ncbi.nlm.nih.gov/24257721/). DOI: 10.3945/ajcn.113.065631. Access: abstract_metadata. Study: CALERIE2-NCT00427193.

29. Racette SB, Barry VG, Bales CW et al. Nutritional quality of calorie restricted diets in the CALERIE™ 1 trial. Experimental gerontology. 2022. [PMID 35643360](https://pubmed.ncbi.nlm.nih.gov/35643360/). DOI: 10.1016/j.exger.2022.111840. Access: abstract_metadata. Study: CALERIE1-pooled-three-sites.

30. Qu Q, Chen Y, Wang Y et al. Lithocholic acid phenocopies anti-ageing effects of calorie restriction. Nature. 2025. [PMID 39695227](https://pubmed.ncbi.nlm.nih.gov/39695227/). DOI: 10.1038/s41586-024-08329-5. Access: abstract_metadata. Study: LCA-2025-programme.

31. Qu Q, Chen Y, Wang Y et al. Lithocholic acid binds TULP3 to activate sirtuins and AMPK to slow down ageing. Nature. 2025. [PMID 39695235](https://pubmed.ncbi.nlm.nih.gov/39695235/). DOI: 10.1038/s41586-024-08348-2. Access: abstract_metadata. Study: LCA-2025-programme.

32. Hofer SJ, Daskalaki I, Bergmann M et al. Spermidine is essential for fasting-mediated autophagy and longevity. Nature cell biology. 2024. [PMID 39117797](https://pubmed.ncbi.nlm.nih.gov/39117797/). DOI: 10.1038/s41556-024-01468-x. Access: abstract_metadata. Study: PMID39117797.

33. Debès C, Papadakis A, Grönke S et al. Ageing-associated changes in transcriptional elongation influence longevity. Nature. 2023. [PMID 37046086](https://pubmed.ncbi.nlm.nih.gov/37046086/). DOI: 10.1038/s41586-023-05922-y. Access: abstract_metadata. Study: PMID37046086.

34. Martin-Montalvo A, Mercken EM, Mitchell SJ et al. Metformin improves healthspan and lifespan in mice. Nature communications. 2013. [PMID 23900241](https://pubmed.ncbi.nlm.nih.gov/23900241/). DOI: 10.1038/ncomms3192. Access: abstract_metadata. Study: PMID23900241.

35. Chen D, Thomas EL, Kapahi P et al. HIF-1 modulates dietary restriction-mediated lifespan extension via IRE-1 in Caenorhabditis elegans. PLoS genetics. 2009. [PMID 19461873](https://pubmed.ncbi.nlm.nih.gov/19461873/). DOI: 10.1371/journal.pgen.1000486. Access: abstract_metadata. Study: PMID19461873.

36. Mei SC, Brenner C et al. Calorie restriction-mediated replicative lifespan extension in yeast is non-cell autonomous. PLoS biology. 2015. [PMID 25633578](https://pubmed.ncbi.nlm.nih.gov/25633578/). DOI: 10.1371/journal.pbio.1002048. Access: abstract_metadata. Study: PMID25633578.

37. Lamming DW, Latorre-Esteves M, Medvedik O et al. HST2 mediates SIR2-independent life-span extension by calorie restriction. Science (New York, N.Y.). 2005. [PMID 16051752](https://pubmed.ncbi.nlm.nih.gov/16051752/). DOI: 10.1126/science.1113611. Access: abstract_metadata. Study: PMID16051752.

38. Wu Z, Isik M, Moroz N et al. Dietary Restriction Extends Lifespan through Metabolic Regulation of Innate Immunity. Cell metabolism. 2019. [PMID 30905669](https://pubmed.ncbi.nlm.nih.gov/30905669/). DOI: 10.1016/j.cmet.2019.02.013. Access: abstract_metadata. Study: PMID30905669.

39. Taylor A, Lipman RD, Jahngen-Hodge J et al. Dietary calorie restriction in the Emory mouse: effects on lifespan, eye lens cataract prevalence and progression, levels of ascorbate, glutathione, glucose, and glycohemoglobin, tail collagen breaktime, DNA and RNA oxidation, skin integrity, fecundity, and cancer. Mechanisms of ageing and development. 1995. [PMID 7540704](https://pubmed.ncbi.nlm.nih.gov/7540704/). DOI: 10.1016/0047-6374(94)01541-s. Access: abstract_metadata. Study: PMID7540704.

40. Diaz-Ruiz A, Di Francesco A, Carboneau BA et al. Benefits of Caloric Restriction in Longevity and Chemical-Induced Tumorigenesis Are Transmitted Independent of NQO1. The journals of gerontology. Series A, Biological sciences and medical sciences. 2019. [PMID 29733330](https://pubmed.ncbi.nlm.nih.gov/29733330/). DOI: 10.1093/gerona/gly112. Access: abstract_metadata. Study: PMID29733330.

41. Ivimey-Cook ER, Sales K, Carlsson H et al. Transgenerational fitness effects of lifespan extension by dietary restriction in Caenorhabditis elegans. Proceedings. Biological sciences. 2021. [PMID 33975472](https://pubmed.ncbi.nlm.nih.gov/33975472/). DOI: 10.1098/rspb.2021.0701. Access: abstract_metadata. Study: PMID33975472.

42. Lin SJ, Kaeberlein M, Andalis AA et al. Calorie restriction extends Saccharomyces cerevisiae lifespan by increasing respiration. Nature. 2002. [PMID 12124627](https://pubmed.ncbi.nlm.nih.gov/12124627/). DOI: 10.1038/nature00829. Access: abstract_metadata. Study: PMID12124627.

43. Xu Y, He Z, Song M et al. A microRNA switch controls dietary restriction-induced longevity through Wnt signaling. EMBO reports. 2019. [PMID 30872315](https://pubmed.ncbi.nlm.nih.gov/30872315/). DOI: 10.15252/embr.201846888. Access: abstract_metadata. Study: PMID30872315.

44. Yu D, Tomasiewicz JL, Yang SE et al. Calorie-Restriction-Induced Insulin Sensitivity Is Mediated by Adipose mTORC2 and Not Required for Lifespan Extension. Cell reports. 2019. [PMID 31577953](https://pubmed.ncbi.nlm.nih.gov/31577953/). DOI: 10.1016/j.celrep.2019.08.084. Access: abstract_metadata. Study: PMID31577953.

45. Rollins JA, Shaffer D, Snow SS et al. Dietary restriction induces posttranscriptional regulation of longevity genes. Life science alliance. 2019. [PMID 31253655](https://pubmed.ncbi.nlm.nih.gov/31253655/). DOI: 10.26508/lsa.201800281. Access: abstract_metadata. Study: PMID31253655.

46. Shimokawa I, Komatsu T, Hayashi N et al. The life-extending effect of dietary restriction requires Foxo3 in mice. Aging cell. 2015. [PMID 25808402](https://pubmed.ncbi.nlm.nih.gov/25808402/). DOI: 10.1111/acel.12340. Access: abstract_metadata. Study: PMID25808402.

47. Charar C, Metsuyanim-Cohen S, Bar DZ et al. Lamin regulates the dietary restriction response via the mTOR pathway in Caenorhabditis elegans. Journal of cell science. 2021. [PMID 34383046](https://pubmed.ncbi.nlm.nih.gov/34383046/). DOI: 10.1242/jcs.258428. Access: abstract_metadata. Study: PMID34383046.

48. Hine C, Harputlugil E, Zhang Y et al. Endogenous hydrogen sulfide production is essential for dietary restriction benefits. Cell. 2015. [PMID 25542313](https://pubmed.ncbi.nlm.nih.gov/25542313/). DOI: 10.1016/j.cell.2014.11.048. Access: abstract_metadata. Study: PMID25542313.

49. Schmeisser S, Priebe S, Groth M et al. Neuronal ROS signaling rather than AMPK/sirtuin-mediated energy sensing links dietary restriction to lifespan extension. Molecular metabolism. 2013. [PMID 24199155](https://pubmed.ncbi.nlm.nih.gov/24199155/). DOI: 10.1016/j.molmet.2013.02.002. Access: abstract_metadata. Study: PMID24199155.

50. Zhang B, Jun H, Wu J et al. Olfactory perception of food abundance regulates dietary restriction-mediated longevity via a brain-to-gut signal. Nature aging. 2021. [PMID 33796867](https://pubmed.ncbi.nlm.nih.gov/33796867/). DOI: 10.1038/s43587-021-00039-1. Access: abstract_metadata. Study: PMID33796867.

51. Weir HJ, Yao P, Huynh FK et al. Dietary Restriction and AMPK Increase Lifespan via Mitochondrial Network and Peroxisome Remodeling. Cell metabolism. 2017. [PMID 29107506](https://pubmed.ncbi.nlm.nih.gov/29107506/). DOI: 10.1016/j.cmet.2017.09.024. Access: abstract_metadata. Study: PMID29107506.

52. Chamoli M, Singh A, Malik Y et al. A novel kinase regulates dietary restriction-mediated longevity in Caenorhabditis elegans. Aging cell. 2014. [PMID 24655420](https://pubmed.ncbi.nlm.nih.gov/24655420/). DOI: 10.1111/acel.12218. Access: abstract_metadata. Study: PMID24655420.

53. Goyala A, Baruah A, Mukhopadhyay A et al. The genetic paradigms of dietary restriction fail to extend life span in cep-1(gk138) mutant of C. elegans p53 due to possible background mutations. PloS one. 2020. [PMID 33180887](https://pubmed.ncbi.nlm.nih.gov/33180887/). DOI: 10.1371/journal.pone.0241478. Access: abstract_metadata. Study: PMID33180887.

54. Allen BD, Liao CY, Shu J et al. Hyperadrenocorticism of calorie restriction contributes to its anti-inflammatory action in mice. Aging cell. 2019. [PMID 30938024](https://pubmed.ncbi.nlm.nih.gov/30938024/). DOI: 10.1111/acel.12944. Access: abstract_metadata. Study: PMID30938024.

55. Haigis MC, Mostoslavsky R, Haigis KM et al. SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell. 2006. [PMID 16959573](https://pubmed.ncbi.nlm.nih.gov/16959573/). DOI: 10.1016/j.cell.2006.06.057. Access: abstract_metadata. Study: PMID16959573.

56. Thompson AC, Bruss MD, Price JC et al. Reduced in vivo hepatic proteome replacement rates but not cell proliferation rates predict maximum lifespan extension in mice. Aging cell. 2016. [PMID 26541492](https://pubmed.ncbi.nlm.nih.gov/26541492/). DOI: 10.1111/acel.12414. Access: abstract_metadata. Study: PMID26541492.

57. Wei F, Liu S, Liu J et al. Separation of reproductive decline from lifespan extension during methionine restriction. Nature aging. 2024. [PMID 39060538](https://pubmed.ncbi.nlm.nih.gov/39060538/). DOI: 10.1038/s43587-024-00674-4. Access: abstract_metadata. Study: PMID39060538.

58. Iiams SE, Skinner NJ, Wight-Carter M et al. Time-restricted feeding extends healthspan in both sexes and lifespan in male C57BL/6 J mice. Nature aging. 2026. [PMID 42230994](https://pubmed.ncbi.nlm.nih.gov/42230994/). DOI: 10.1038/s43587-026-01129-8. Access: abstract_metadata. Study: PMID42230994.

59. Martin CK, Bhapkar M, Pittas AG et al. Effect of Calorie Restriction on Mood, Quality of Life, Sleep, and Sexual Function in Healthy Nonobese Adults: The CALERIE 2 Randomized Clinical Trial. JAMA internal medicine. 2016. [PMID 27136347](https://pubmed.ncbi.nlm.nih.gov/27136347/). DOI: 10.1001/jamainternmed.2016.1189. Access: abstract_metadata. Study: CALERIE2-NCT00427193.

60. Villareal DT, Chode S, Parimi N et al. Weight loss, exercise, or both and physical function in obese older adults. The New England journal of medicine. 2011. [PMID 21449785](https://pubmed.ncbi.nlm.nih.gov/21449785/). DOI: 10.1056/NEJMoa1008234. Access: abstract_metadata. Study: NCT00146107.

## Source-specific evidence cards

### [1] Dietary restriction impacts health and lifespan of genetically diverse mice.

**Shows:** Adult-onset restriction extended survival in genetically diverse female mice; health measures did not uniformly track survival.

**Does not show:** Restriction included daily/weekend fasting, and measured-trait path analysis is not selective mediator intervention.

**Access/status:** Complete primary abstract and linked-status metadata examined. Selected body sections: Sec1, Sec2, Sec6, Sec11, Sec26. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2.

### [2] Circadian alignment of early onset caloric restriction promotes longevity in male C57BL/6J mice.

**Shows:** Equal-calorie regimens separated restriction, fasting and circadian timing; spread feeding still extended median survival.

**Does not show:** The single male strain and differing maximum-survival results limit generalization; timing contributes substantially.

**Access/status:** Complete primary abstract and linked-status metadata examined. Selected body sections: S2. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2.

### [3] Fasting drives the metabolic, molecular and geroprotective effects of a calorie-restricted diet in mice.

**Shows:** Separated feeding regimens attributed key mouse CR benefits to prolonged fasting.

**Does not show:** The tested protocols do not establish that all calorie restriction effects in all species are solely fasting effects.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2.

### [4] Dietary restriction of isoleucine increases healthspan and lifespan of genetically heterogeneous mice.

**Shows:** Isoleucine restriction improved frailty/metabolism and extended lifespan in genetically heterogeneous mice of both sexes.

**Does not show:** Nutrient-specific effects and sex differences distinguish this intervention from pure calorie reduction.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2.

### [5] Calorie restriction increases insulin sensitivity to promote beta cell homeostasis and longevity in mice.

**Shows:** CR preserved beta-cell structure/function and reduced turnover but impaired adaptive proliferation during high-fat feeding.

**Does not show:** Cell longevity and beta-cell markers are not a new organismal survival endpoint in this report.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. UpdateOf: PMID37790446. Subclaims: SC2.

### [6] Caloric restriction delays disease onset and mortality in rhesus monkeys.

**Shows:** Adult-onset Wisconsin rhesus restriction reduced age-associated deaths and disease onset.

**Does not show:** Age-related mortality at this report is not identical to an all-cause complete-survival result; human lifespan is not measured.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC3.

### [7] Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study.

**Shows:** The NIA rhesus CR regimen did not improve survival despite reported health benefits.

**Does not show:** Differences in baseline intake, diet and age of initiation limit direct comparison with Wisconsin.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC3.

### [8] Caloric restriction improves health and survival of rhesus monkeys.

**Shows:** Joint longitudinal analysis compared the divergent rhesus survival results and conserved health benefits.

**Does not show:** These are the same NIA/Wisconsin cohorts, not a third independent primate replication.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC3.

### [9] Mortality and morbidity in laboratory-maintained Rhesus monkeys and effects of long-term dietary restriction.

**Shows:** Long-term laboratory rhesus data associated restriction with lower mortality and better insulin sensitivity.

**Does not show:** Only eight restricted monkeys and unequal cohort sizes limit causal precision and human inference.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC3.

### [10] Activity measures in rhesus monkeys on long-term calorie restriction.

**Shows:** Long-term rhesus CR increased selected activity measures in one age group.

**Does not show:** Movement, pacing and stereotypies do not by themselves establish lifespan extension or uniformly improved function.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1.

### [11] Caloric restriction delays aging-induced cellular phenotypes in rhesus monkey skeletal muscle.

**Shows:** Rhesus CR preserved upper-leg mass/fiber features during early sarcopenia.

**Does not show:** It did not prevent mitochondrial deletion abnormalities; shared Wisconsin animals are not new survival replication.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1.

### [12] Molecular and Functional Networks Linked to Sarcopenia Prevention by Caloric Restriction in Rhesus Monkeys.

**Shows:** Rhesus muscle metabolic/tissue profiles linked CR to preserved muscle and physical activity.

**Does not show:** Integrated profiling suggests candidate routes without selectively testing their necessity.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2.

### [13] Calorie restriction in nonhuman primates: effects on diabetes and cardiovascular disease risk.

**Shows:** Reported NIA primary measurements showed favorable cardiovascular/metabolic risk changes, including short-term changes in older monkeys.

**Does not show:** The report's broader background is not counted as new evidence; risk-factor change is not a human mortality outcome.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC3.

### [14] Caloric Restriction Engages Hepatic RNA Processing Mechanisms in Rhesus Monkeys.

**Shows:** Longitudinal rhesus liver profiling showed CR-associated metabolic and RNA-processing changes.

**Does not show:** Predictive network analysis does not prove a unified required mediator.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2.

### [15] Metabolizable energy intake during long-term calorie restriction in rhesus monkeys.

**Shows:** Bomb calorimetry quantified the actual restricted versus control energy exposure in old rhesus monkeys.

**Does not show:** An exposure-measurement report is not a separate lifespan intervention or mechanistic line.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1.

### [16] A 2-Year Randomized Controlled Trial of Human Caloric Restriction: Feasibility and Effects on Predictors of Health Span and Longevity.

**Shows:** CALERIE achieved sustained moderate restriction and favorable risk measures; the primary resting-metabolic residual contrast was significant at twelve but not twenty-four months.

**Does not show:** Neither mortality nor extended healthy lifespan was measured; the linked erratum's fine impact remains unresolved.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. ErratumIn: PMID27059599. Subclaims: SC3, SC4.

### [17] 2 years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial.

**Shows:** CALERIE exploratory randomized outcomes improved several cardiometabolic risk factors over two years.

**Does not show:** Risk factors, including insulin sensitivity, are not validated CR-mediated lifespan surrogates or a new independent cohort.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC3, SC4.

### [18] Calorie restriction increases muscle mitochondrial biogenesis in healthy humans.

**Shows:** Six-month CR changed human muscle mitochondrial DNA and transcripts and reduced DNA damage.

**Does not show:** Key mitochondrial enzyme activities were unchanged; molecular markers do not establish lifespan extension.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC3.

### [19] Calorie restriction and bone health in young, overweight individuals.

**Shows:** Six-month CR changed bone turnover without significant total/hip density loss in young overweight adults.

**Does not show:** Short duration and nutrient support do not exclude longer-term bone or fracture harm.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC4.

### [20] Associations between the timing of eating and weight-loss in calorically restricted healthy adults: Findings from the CALERIE study.

**Shows:** Secondary CALERIE modeling associated meal timing with weight loss beyond restriction.

**Does not show:** Timing was not independently randomized and the analysis does not establish lifespan mediation.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC4.

### [21] Caloric restriction, resting metabolic rate and cognitive performance in Non-obese adults: A post-hoc analysis from CALERIE study.

**Shows:** Post hoc CALERIE analysis linked metabolic-rate changes to cognitive performance under CR.

**Does not show:** Moderation and component associations are not a prespecified isolated cognitive mechanism trial.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC4.

### [22] Association between the FTO rs9939609 single nucleotide polymorphism and dietary adherence during a 2-year caloric restriction intervention: Exploratory analyses from CALERIE™ phase 2.

**Shows:** FTO genotype did not significantly alter restriction adherence or most aging-related biomarker changes.

**Does not show:** An exploratory subgroup association is not a Mendelian instrument for lifelong calorie exposure or survival.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC3, SC4.

### [23] Calorie restriction reduces biomarkers of cellular senescence in humans.

**Shows:** CALERIE samples showed reduced circulating senescence-associated markers and an adipose gene-set signal.

**Does not show:** Markers and machine-learning prediction of metabolic change do not establish clinical aging reversal.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC3.

### [24] Caloric restriction in humans reveals immunometabolic regulators of health span.

**Shows:** Human CR improved thymopoiesis; mouse Pla2g7 deletion improved inflammation and metabolic phenotypes.

**Does not show:** Human correlation plus mouse deletion is not selectively identified human mediator necessity or mortality benefit.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC4.

### [25] Reduction of SPARC protects mice against NLRP3 inflammasome activation and obesity.

**Shows:** Human adipose SPARC reduction motivated inducible adult mouse downregulation and adipocyte deletion with metabolic/inflammatory benefit.

**Does not show:** CR-like disease physiology is not a measured general lifespan outcome or uniquely necessary CR coordinator.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2.

### [26] Calorie restriction modulates the transcription of genes related to stress response and longevity in human muscle: The CALERIE study.

**Shows:** CALERIE muscle biopsies showed transcription/splicing changes with preserved strength despite minor lean loss.

**Does not show:** Statistical pathway mediation and muscle quality are not proof of longer human survival.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC4.

### [27] Effect of long-term caloric restriction on DNA methylation measures of biological aging in healthy adults from the CALERIE trial.

**Shows:** Post hoc CALERIE analysis changed DunedinPACE but not PhenoAge/GrimAge significantly.

**Does not show:** The primary discussion explicitly requires clinical endpoint follow-up to validate intervention-surrogate mediation; correction remains attached.

**Access/status:** Complete primary abstract and linked-status metadata examined. Selected body sections: Sec1. No complete-paper or supplement audit claimed. ErratumIn: PMID37161091. Subclaims: SC3.

### [28] Energy requirements in nonobese men and women: results from CALERIE.

**Shows:** Doubly labeled water demonstrated reliable energy requirements and substantial self-report intake underestimation.

**Does not show:** Baseline exposure calibration improves trial interpretation but does not add a survival result.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC3.

### [29] Nutritional quality of calorie restricted diets in the CALERIE™ 1 trial.

**Shows:** CALERIE phase1 food diaries showed nutritional quality maintained or improved under supervised restriction.

**Does not show:** Not every nutrient reached adequacy in every participant; nutritional quality is not a mortality endpoint.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC3, SC4.

### [30] Lithocholic acid phenocopies anti-ageing effects of calorie restriction.

**Shows:** Lithocholic acid improved aged-mouse function and extended worm/fly lifespan with AMPK dependence.

**Does not show:** Mouse functional rescue is distinct from mouse survival; linked correction details were not fully examined.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. ErratumIn: PMID39875609. Subclaims: SC1, SC2.

### [31] Lithocholic acid binds TULP3 to activate sirtuins and AMPK to slow down ageing.

**Shows:** LCA-TULP3-sirtuin-vATPase signaling and a muscle mutant linked AMPK to aged-mouse function and worm/fly longevity.

**Does not show:** Companion work shares the LCA programme and is not an independent lab replication or complete CR necessity test.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2.

### [32] Spermidine is essential for fasting-mediated autophagy and longevity.

**Shows:** Genetic/pharmacologic polyamine-pathway perturbation abrogated fasting-related autophagy and longevity/health effects in models.

**Does not show:** Human metabolite changes are not a human longevity intervention; fasting is not identical to calorie restriction.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2.

### [33] Ageing-associated changes in transcriptional elongation influence longevity.

**Shows:** Slower RNA polymerase variants extended worm/fly lifespan while restriction reversed age-linked elongation changes.

**Does not show:** Human cell division capacity is not organismal human lifespan; the complete CR pathway is not isolated.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2.

### [34] Metformin improves healthspan and lifespan in mice.

**Shows:** Middle-age low-dose metformin improved male-mouse survival/function; high dose was toxic without calorie reduction.

**Does not show:** A partial CR mimetic is a comparator, not evidence that one conserved CR coordinator is sufficient across humans.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2.

### [35] HIF-1 modulates dietary restriction-mediated lifespan extension via IRE-1 in Caenorhabditis elegans.

**Shows:** HIF-1/egl-9 perturbation and tissue rescue linked nutrient-dependent worm longevity to IRE-1.

**Does not show:** Nutrient context and tissue-specificity constrain the pathway; cross-species unity is not shown.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2.

### [36] Calorie restriction-mediated replicative lifespan extension in yeast is non-cell autonomous.

**Shows:** Moving yeast mothers removed CR replicative longevity, restored by supplements or conditioned medium; the transferable factor was Sir2-independent.

**Does not show:** Replicative cell aging and media ecology differ from adult animal or human aging.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2.

### [37] HST2 mediates SIR2-independent life-span extension by calorie restriction.

**Shows:** Yeast Hst2 mediated Sir2-independent lifespan extension under restriction.

**Does not show:** Redundant sirtuin routes challenge single-Sir2 necessity and do not establish a human longevity mechanism.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2.

### [38] Dietary Restriction Extends Lifespan through Metabolic Regulation of Innate Immunity.

**Shows:** Worm p38-ATF7 immune signaling had to be intact but downregulated for dietary longevity.

**Does not show:** Immune and nutrient pathways are context dependent; correction-body details remain unexamined.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. ErratumIn: PMID34614410. Subclaims: SC1, SC2.

### [39] Dietary calorie restriction in the Emory mouse: effects on lifespan, eye lens cataract prevalence and progression, levels of ascorbate, glutathione, glucose, and glycohemoglobin, tail collagen breaktime, DNA and RNA oxidation, skin integrity, fecundity, and cancer.

**Shows:** Emory-mouse restriction extended median survival and reduced cataract/cancer measures.

**Does not show:** Single-background findings and some adverse tissue signs limit universal healthspan alignment.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1.

### [40] Benefits of Caloric Restriction in Longevity and Chemical-Induced Tumorigenesis Are Transmitted Independent of NQO1.

**Shows:** NQO1 knockout retained CR benefits for lifespan, metabolic function and carcinogen outcomes.

**Does not show:** NQO1 upregulation is not necessary for these tested benefits; retained pathways do not identify a unified alternative.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2.

### [41] Transgenerational fitness effects of lifespan extension by dietary restriction in Caenorhabditis elegans.

**Shows:** Temporary fasting reduced parental worm mortality but produced adverse multigenerational fitness/survival tradeoffs.

**Does not show:** Generation and exposure schedules limit a universal benefit claim.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2.

### [42] Calorie restriction extends Saccharomyces cerevisiae lifespan by increasing respiration.

**Shows:** Yeast glucose restriction/PKA perturbation linked respiration and Sir2/NAD to replicative lifespan.

**Does not show:** Strain and replicative-aging conditions do not establish the same necessary route in other species.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2.

### [43] A microRNA switch controls dietary restriction-induced longevity through Wnt signaling.

**Shows:** Adult-onset microRNA/Wnt switching was required for worm dietary longevity.

**Does not show:** The temporal switch helps separate development, but the specific route remains a worm context.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2.

### [44] Calorie-Restriction-Induced Insulin Sensitivity Is Mediated by Adipose mTORC2 and Not Required for Lifespan Extension.

**Shows:** Adipose Rictor deletion blocked CR insulin sensitization while preserving fitness and lifespan extension.

**Does not show:** This directly separates a familiar metabolic marker from the required survival mediator.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2.

### [45] Dietary restriction induces posttranscriptional regulation of longevity genes.

**Shows:** RNAi tests identified nonsense-mediated-decay genes required for worm dietary longevity.

**Does not show:** Transcript/translatome associations alone are not mediator proof; RNAi survival tests retain their specific scope.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2.

### [46] The life-extending effect of dietary restriction requires Foxo3 in mice.

**Shows:** Foxo3-deficient mice failed to show significant CR lifespan extension while cancer suppression persisted.

**Does not show:** The reported absence of significance and one genetic setting do not establish universal Foxo3 necessity across all CR protocols.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2.

### [47] Lamin regulates the dietary restriction response via the mTOR pathway in Caenorhabditis elegans.

**Shows:** Lamin downregulation altered dietary-restriction size/fat phenotypes via RAGC/mTOR localization in worms.

**Does not show:** This report does not supply a new organismal lifespan rescue result in the examined abstract.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2.

### [48] Endogenous hydrogen sulfide production is essential for dietary restriction benefits.

**Shows:** Sulfur-amino-acid/CGL perturbations blocked DR hepatic stress protection; transsulfuration changes appeared across longevity models.

**Does not show:** Injury resistance and across-model pathway occurrence do not alone prove a common lifespan mediator.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2.

### [49] Neuronal ROS signaling rather than AMPK/sirtuin-mediated energy sensing links dietary restriction to lifespan extension.

**Shows:** Complex-I inhibition extended worm lifespan without reduced intake; neuronal ROS/PMK/SKN perturbations blocked the effect despite AMPK/sirtuin independence.

**Does not show:** A DR-like pharmacological route is not proof that every dietary protocol uses that mechanism.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2.

### [50] Olfactory perception of food abundance regulates dietary restriction-mediated longevity via a brain-to-gut signal.

**Shows:** Food odors shortened DR worm lifespan through an olfactory brain-gut octopamine/AMPK route.

**Does not show:** Perceived food cues modify dietary longevity; mouse primary-cell signaling is not mouse or human lifespan.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2.

### [51] Dietary Restriction and AMPK Increase Lifespan via Mitochondrial Network and Peroxisome Remodeling.

**Shows:** Fusion/fission, fatty-acid oxidation and peroxisomal perturbations separated DR/AMPK/fasting worm longevity requirements.

**Does not show:** Different dynamic versus stabilized network requirements constrain a unified explanation.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2.

### [52] A novel kinase regulates dietary restriction-mediated longevity in Caenorhabditis elegans.

**Shows:** mekk-3 knockdown induced a dietary-like longevity state without compromised food intake in worms.

**Does not show:** A genetic mimetic distinguishes sensing from calorie dose but does not establish human extension.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2.

### [53] The genetic paradigms of dietary restriction fail to extend life span in cep-1(gk138) mutant of C. elegans p53 due to possible background mutations.

**Shows:** A cep-1 strain blocked genetic but not nongenetic dietary longevity; authors implicated background mutations.

**Does not show:** The result cannot be attributed specifically to p53 without resolving linked genetic background.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2.

### [54] Hyperadrenocorticism of calorie restriction contributes to its anti-inflammatory action in mice.

**Shows:** Corticosterone replacement restored CR attenuation of edema in hormone-insufficient mice.

**Does not show:** Anti-inflammatory challenge response is not directly measured lifespan mediation.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2.

### [55] SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells.

**Shows:** SIRT4 loss and CR altered beta-cell GDH/insulin regulation through NAD-dependent modification.

**Does not show:** This cell/tissue metabolic result does not establish organismal lifespan necessity or a uniform sirtuin activation rule.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2.

### [56] Reduced in vivo hepatic proteome replacement rates but not cell proliferation rates predict maximum lifespan extension in mice.

**Shows:** Hepatic protein replacement rates associated with lifespan extension across mouse interventions.

**Does not show:** Cross-model biomarker correlation is not causal mediation or another independent survival test.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2.

### [57] Separation of reproductive decline from lifespan extension during methionine restriction.

**Shows:** Folate supplementation preserved methionine-restriction fly longevity while restoring reproductive capacity.

**Does not show:** Defined nutrient balance can separate tradeoffs; this is not pure calorie restriction or human lifespan.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2.

### [58] Time-restricted feeding extends healthspan in both sexes and lifespan in male C57BL/6 J mice.

**Shows:** Nightly time-restricted feeding improved both-sex health measures, while survival extended only in male mice under the shorter window.

**Does not show:** The strongest group also voluntarily restricted calories; sex and calorie/time factors remain material.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. UpdateOf: PMID41280091. Subclaims: SC1, SC2.

### [59] Effect of Calorie Restriction on Mood, Quality of Life, Sleep, and Sexual Function in Healthy Nonobese Adults: The CALERIE 2 Randomized Clinical Trial.

**Shows:** CALERIE randomized restriction improved selected mood, general-health and sexual-function questionnaire outcomes.

**Does not show:** Self-report and unblinded diet intervention limit interpretation; benefits are not durable disease-free survival.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC4.

### [60] Weight loss, exercise, or both and physical function in obese older adults.

**Shows:** Randomized diet-induced weight loss improved physical performance in older obese adults; exercise combination produced larger gains.

**Does not show:** Diet alone also reduced lean mass and hip density; the obesity-treatment context does not establish nonobese human lifespan extension.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC4.